Biovet - the leading European manufacturer in the field of biotechnology

Biovet AD is the manufacturing arm of Huvepharma - leading and fast growing top 10 animal health company, focused on veterinary products, feed additives, and vaccines for the live stock segment. Biovet is amongst the largest fermentation companies in Europe and the world, operating in excess of 10,000,000 Liters of fermentation capacity.

In addition to manufacturing fermentation derived animal health products for Huvepharma, Biovet manufactures and is licensed to manufacture by fermentation food ingredients and enzymes, flavors and fragrances, nutritional and vitamin products. Biovet holds GMP for animal and human health products from both the EU and USFDA.

The food related products and ingredients are manufactured according to the highest quality standard for food products - FSSC 22000 quality system and could also be Kosher and Halal certified.  This allows the company to service the global food markets. Biovet has a proven track record in managing investments in large production and energy related projects.

Our services

We offer our client process development and scale-up services for biotechnology products. Contract manufacturing service for industrial scale production of fermentation driven products including different down-stream/purification possibility such as filtration, ion-exchange, extraction, drying etc. We offer process development and pilot scale production from 20l up to 10.000 l. Biovet can offer industrial fermentation scales from 15 m³ up to 160 m³ and related DSP capacities.

Quality and Regulation

Our fully integrated services are underscored by our commitment to quality and the operational excellence that flows through our best-in-class process and cGMP manufacturing capabilities, meeting FDA, EMA, ISO and FSSC standards.

Biovet has been certified according to cGMP by FDA and EU. Biovet has implemented an integral management system for quality management and environmental protection.

The company is focused and committed to continuously reducing the carbon footprint by various initiatives. Currently 25% of energy utilized comes from own renewable sources.  Biovet is committed by 2030 to reach carbon neutrality.

Partnership and Cooperations

Biovet can offer contract manufacturing, partnership and other types cooperation to ensure successful development and industrial scale production.